Topic - antibody

avatar
Biosciences

Scientists Discover Weakness in HIV

Protein discovery could be the key to an HIV vaccine.
avatar
Biosciences

GlycoFi Gets Its Crown Jewel

The Merck subsidiary has yeast that can copy human cell chemistry.
avatar
Biosciences, Finance

Belgian Biotech Garners $51M

Ablynx scores one of the year’s top European biotech deals.
avatar
Biosciences

Gene Therapy’s Reemergence

The technology is generating renewed interest in the VC and medical communities.
avatar
Biosciences

Viruses May Be Fattening

Scientists find evidence to suggest viral infection may be cause of human obesity.
avatar
Biosciences, Finance

Yeast Helps Drugs Work Better

Biotech firm GlycoFi shows that yeast can improve drug function by helping control the drug’s molecular structure.
avatar
Biosciences

Abbott in $255M Humira Deal

The health care company agrees to pay Cambridge Antibody Technology the sum instead of future royalties.
avatar
Biosciences

Celldex Buys Lorantis, Alteris

Celldex Therapeutics acquires two biotechnology companies as Medarex takes a 60 percent stake in the company.
avatar
Biosciences

Genentech’s Patent Woes

U.S. patent office rejects pharma giant's antibody-manufacturing methods patent.
avatar
Biosciences

Origen Gets Antibodies in Eggs

Origen Therapeutics has produced transgenic chickens that lay eggs containing human antibodies.
avatar
Biosciences

West Nile Study Raises Hope

Researchers at MacroGenics and Washington University have produced the first promising treatment for West Nile virus.
avatar
Archives, Magazine

Genentech: Antibody warriors

Genentech: Antibody warriors